Striatal monoamines and reserpine and chlorpromazine rigidity

scientific article published on January 1, 1976

Striatal monoamines and reserpine and chlorpromazine rigidity is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/0306-039X(76)90024-6
P953full work available at URLhttps://api.elsevier.com/content/article/PII:0306039X76900246?httpAccept=text/plain
https://api.elsevier.com/content/article/PII:0306039X76900246?httpAccept=text/xml
P698PubMed publication ID178006

P2093author name stringI. Jurna
P2860cites workphenothiazineQ16023748
3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonistsQ34242473
Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal systemQ34248307
EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.Q34540614
Effects of amphetamine, tyramine, and protriptyline on reserpine-resistant amine-concentrating mechanisms of adrenergic nervesQ68719581
Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-HydroxydopamineQ68730942
Depression by amantadine of drug-induced rigidity in the ratQ70426548
Evidence that the CCENTRAL ACTION OF (+)-amphetamine is mediated via catecholaminesQ71888449
Degeneration of adrenergic nerves produced by 6-hydroxydopamineQ72055622
Inhibitors of purified beef adrenal tyrosine hydroxylaseQ72583406
Refillment of the catecholamine stores with 3,4-dihydroxyphenylalanine after depletion induced by inhibition of tyrosine-hydroxylaseQ72904759
Reciprocal effects on alpha- and gamma-motoneurones of drugs influencing monoaminergic and cholinergic transmissionQ72918845
The vasopressor action and toxicity of cyclohexylethylamine derivativesQ72990162
EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONSQ78452934
The development of current concepts of catecholamine formationQ78711283
The comparative pressor activity of the optical isomers of cyclohexylisopropylamine and cyclohexylisopropylmethylamineQ80366823
???Q94271328
PHARMACOLOGICAL ASPECTS OF PARKINSONISM.Q35475174
Some aspects of the effects of acute reserpine treatment on behaviourQ39476269
The effects of atropine and dyflos on tremor and increase in whole brain acetylcholine produced by injection of oxotremorine in the ratQ41352012
The action of dopamine on neurones of the caudate nucleusQ41512601
Dopamine receptor blockade--a central action of chlorpromazine on striatal neurones.Q42439044
Effects of amantadine on uptake and release of dopamine by a particulate fraction of rat basal ganglia.Q42439051
Functional role of the nigro-neostriatal dopamine neuronsQ42442278
Synaptic excitation in the corpus striatum inhibited by microelectrophoretically administered dopamineQ42444418
DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.Q42449524
An electron microscopic study of selective, acute degeneration of sympathetic nerve terminals after administration of 6-hydroxydopamineQ43682060
THE EFFECT OF L-3, 4-DIHYDROXYPHENYLALANINE AND DL-5-HYDROXYTRYPTOPHAN ON RIGIDITY AND TREMOR INDUCED BY RESERPINE, CHLORPROMAZINE AND PHENOXYBENZAMINE.Q44589521
Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brainQ45244713
Modification of Parkinsonism--chronic treatment with L-dopaQ45300970
Conversion of L-tyrosine to 3,4-dihydroxyphenylalanine by cell-free preparations of brain and sympathetically innervated tissuesQ46778622
The dependence of the anti-nociceptive effect of morphine and other analgesic agents on spinal motor activity after central monoamine depletionQ48627104
Comparison of effects of L-dopa, amphetamine and apomorphine on firing rate of rat dopaminergic neuronesQ48630899
Release of endogenously synthetized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamineQ48681697
The effect of α-methyl-p-tyrosine and substantia nigra lesions on spinal motor activity in the ratQ48712341
Increased synthesis and release of dopamine in the striatum of the rat after amantadine treatmentQ48944131
Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neuronsQ49009961
Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the ratQ49015081
6-hydroxy-dopamine induced degeneration of central monoamine neuronsQ49122002
Effects of amantadine hydrochloride on catecholamine metabolism in the brain of the rat.Q51108567
The release of H3-dopamine from cat brain following electrical stimulation of the substantia nigra and caudate nucleusQ51117841
Dopamine: Release from the Brain in vivo by AmantadineQ51118984
Dopamine: spontaneous and drug-induced release from the caudate nucleus in the cat.Q51120979
Caudate nucleus neurones: correlation of the effects of substantia nigra stimulation with iontophoretic dopamineQ51142774
Caudate unit responses to nigral stimuli: evidence for a possible nigro-neostriatal pathway.Q51185478
The influence of microelectrophoretically applied biogenic amines, cholinomimetics and procaine on synaptic excitation in the corpus striatum.Q51185764
In vitro studies on central and peripheral monoamine neurons at the ultrastructural levelQ51193185
Striatal and spinal lesions eliminating reserpine and physostigmine rigidityQ51204576
The effect of some psychoactive drugs on central monoamine neurons.Q51207602
Evidence for dopamine receptor stimulation by apomorphine.Q51208002
The effect of neuroleptics on the activity of central catecholamine neurones.Q51215941
Cholinergic mechanisms in the caudate nucleusQ51227230
On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels.Q51230297
Biochemical and histochemical studies on the effects of imipramine-like drugs and (+)-amphetamine on central and peripheral catecholamine neurons.Q51232404
Effects of certain tranquillisers on the level of homovanillic acid in the corpus striatum.Q51245443
SITE OF ACTION OF RESERPINE.Q51257953
On the presence of 3-hydroxytyramine in brain.Q51322287
Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat.Q51331651
Chlorpromazine and reserpine in the treatment of psychosesQ52172256
Clinical effectiveness of reserpineQ52172259
Use of reserpine in a neuropsychiatric hospitalQ52172272
Chlorpromazin und Spastizit�tQ56812437
Mode of action of apomorphine and dexamphetamine on gnawing compulsion in ratsQ67218875
Supraspinal and drug modulation of the alpha motor system.Q67223446
[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]Q67224247
[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].Q67224420
Inhibition of the effect of reserpine on motor control by drugs which influence reserpine rigidityQ68434318
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectstriatumQ1319792
chlorpromazineQ407972
P304page(s)113-128
P577publication date1976-01-01
P1433published inPharmacology & TherapeuticsQ3378596
P1476titleStriatal monoamines and reserpine and chlorpromazine rigidity
P478volume2

Reverse relations

cites work (P2860)
Q48954838Effects of striatal and pallidal lesions and intrapallidal GABA and opiate drugs on tremorine-induced rigidity in the rat
Q39867379Impaired dopamine function and muscular rigidity induced by 6-aminonicotinamide in rats
Q67045879Lisuride, a potent drug in the treatment of muscular rigidity in rats
Q48315924Specific action of narcotics on reflex activation of rat alpha-motoneurones

Search more.